Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
โ ๏ธ The MHRA has reported 3 confirmed cases of progressive multifocal encephalopathy (PML) that developed 6 months to several years after cladribine treatment for haematological conditions. Always consider this rare but serious risk.
| Name | Starting Dose | Frequency | Route |
|---|---|---|---|
| Cladribine (haematology) | 0.1โ0.14 mg/kg/day | Daily ร 5โ7 days | IV infusion |
| Cladribine (MS โ Mavencladยฎ) | 3.5 mg/kg total cumulative dose over 2 years | Given in 2 annual courses | PO (tablets) |
โ ๏ธ Exact dosing varies by indication โ always verify with BNF/SmPC.